Integrated BioPharma, Inc. (OTCMKTS:INBP) Short Interest Update

Integrated BioPharma, Inc. (OTCMKTS:INBP) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 4,800 shares, a growth of 1,500.0% from the February 28th total of 300 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 16,900 shares, the short-interest ratio is presently 0.3 days.

Integrated BioPharma Trading Up 13.3 %

Shares of INBP stock traded up $0.04 during trading on Wednesday, hitting $0.34. The company’s stock had a trading volume of 17,845 shares, compared to its average volume of 19,815. The business has a fifty day moving average of $0.33 and a 200-day moving average of $0.31. The company has a market cap of $10.30 million, a PE ratio of 11.34 and a beta of 0.89. Integrated BioPharma has a 52 week low of $0.16 and a 52 week high of $0.42.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.